top of page
Image-empty-state_edited.jpg

General Genomics Inc.

Favorite-Icon-p-1600.png
Favorite-Icon-p-1600_filled.png
Login to favorite a company
Accurately predict your risk of infectious disease (like COVID) and take control
Most Recent Valuation:

$50,000,000.00

Legal Name:
Founded:
State of HQ:

General Genomics Inc.

4/9/2020

TX

Company Description

Employees:

6

Funding Summary

Number of funding rounds
1
Total amount raised
$26,550
Round name
End date
Raised
Status
Type
Investment minimum
Valuation
Valuation Cap
Price per share
General Genomics SAFE 1
05/31/2021
$26,550.00
closed
SAFE
$100
$50,000,000
Screen Shot 2020-07-15 at 12.01.28 PM.pn

See round history

Round history

Round name
Perk description
Perk level (dollars)
Perk level (days)
Loading...

Early Bird Perk history

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, deal notes, company financials, and more

Company notes

Type
Round name
Date Added
Date Updated
Notes
Loading...

Financials (up to prior 4 years)

Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities

2019

219313
23565
195748
830.67
0
502615
-526180
158806
236696
92032
487534
17382
65829
404323

2018

0
0
0
na
0
0
0
0
0
0
0
0
0
0

Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.

bottom of page